Parallel export and import
Parallel imports and exports are based on a fundamental principle of the European Union, namely the free circulation of goods and services. This means that medicines can be purchased and sold across national borders, while keeping the international rules of pharmaceutical trade. Parallel exports therefore are medicines that are sold to another European Member State (or even a European country outside the EU) and are then distributed by the parallel importer on its domestic market.
This means that authorized pharmaceutical wholesalers may import, export and sell medicines. Parallel importing/exporting are a strictly regulated and safety-conscious industry. The importer and exporter moreover, has to meet the strictest legal safety and quality requirements among others.
An imported medicine for instance has to have identical therapeutic properties as the reference medicine that is already on the market in the importing country. These conditions impose a considerable number of restrictions therefore.
Our partners from Netherlands, Germany, the United Kingdom, Denmark and Poland are already completely familiar with medicines from other EU countries. Parallel imports of medicines in these countries have been customary and accepted for numerous years. Hungarian companies moreover have been exporting significant volumes of medicines to other EU countries for years as part of the same procedure.